From Insight to Action: Why Many Teams Stall at the Last Mile

Gathering insight is one thing. Acting on it fast enough to matter? That’s the real differentiator. Across pharma and biotech, manufacturers invest heavily in market access research—payer interviews, advisory panels, and data dashboards that reveal how coverage...

Designing PAPs That Withstand Scrutiny

By Mary Lynn Kelley, President, eMAX Health Patient Services Patient Assistance Programs are critical to ensuring access for those who need it most — but building one that’s both effective and compliant is increasingly complex. Across my years in patient services,...

Linked EMR + Claims Data for Stronger HEOR Evidence

Manufacturers know that evidence is currency in payer negotiations. Fragmented datasets only tell a partial story that leaves payers skeptical. That’s why linked datasets have become the gold standard for health economics and outcomes research (HEOR). EMRClaims+ from...